A study to compare the effect of Vijay Churna and Pippalyadi Churna in the management of inflammatory (swelling) arthritis (joint pain)

An open randomized comparative clinical study of Vijay churna and Pippalyadi churna in the management of Aam in Aamvata. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/109168

Enrollment

Registered

2026-04-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical sign and symptoms of aam like aruchi, apaaka, angamarda, ruja, jwar anubhuti ,gaatra stabdhata, aalasya, gaurav, vid vibhanda, bahumutrata, shoth, trushna, vairasya, angaraag. Patients who have given written consent. Patients who are willing to adhere to the study protocol and follow-up schedule.

Exclusion criteria

Exclusion criteria: Pregnant women and lactating mothers. Patients with comorbidities like diabetes mellitus, hypertension, cardiovascular disease, CA, Renal failure, Koch s. Patients who are not willing to participate. Patients already on steroid therapy. Patients who have undergone any major surgery within the last 6 months.

Design outcomes

Primary

Measure	Time frame
To study mode of action of Vijay Churna and Pippalyadi Churna on following subjective symptoms of Aamvata. Aruchi Apaaka Trushna Vairasya Vid vibandha Anga marda Aalasya Gaurav Jwar anubhuti Bahumootrata Gaatra stabdhata Shotha Ruja Anga raagTimepoint: 3 weeks	—

Secondary

Measure	Time frame
To assess the onset of action and duration of symptomatic relief in both treatment groups. To assess the safety and tolerability of Vijay Churna and Pippalyadi Churna in the management of Aamvata. To observe and compare any adverse drug reactions or side effects during the treatment. Timepoint: 3 weeks	—

Countries

India

Contacts

Public ContactDr Priya Gupta

APMS Ayurved Mahavidyalaya, Sion

anayapathrikar@gmail.com9870214595

Outcome results